By Laura Lutz
Des Moines, Nov. 8 - ConjuChem Biotechnologies Inc. arranged a public offering of units for C$120.25 million.
The underwriters, a syndicate led by Dundee Securities Corp. and including Sprott Securities Inc., Orion Securities Inc. and Versant Partners Inc., have agreed to purchase 57.69 million units of one share and one half-share warrant at C$0.65 per unit.
They will also offer up to 127.31 additional units at the same price on a best-efforts basis.
Each whole warrant will be exercisable at C$1.00 for three years.
Montreal-based ConjuChem develops medicines from therapeutic peptides.
| Issuer: | ConjuChem Biotechnologies Inc.
|
| Issue: | Units of one share and one half-share warrant
|
| Amount: | C$120.25 million
|
| Units: | 185 million
|
| Price: | C$0.65
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Three years
|
| Warrant strike price: | C$1.00
|
| Underwriters: | Dundee Securities Corp. (lead), Sprott Securities Inc., Orion Securities Inc., Versant Partners Inc.
|
| Pricing date: | Nov. 8
|
| Stock symbol: | Toronto: CJB
|
| Stock price: | C$1.02 at close Nov. 8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
